Castle Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.35 | -$0.32 | -$0.33 |
| Q2 2024 | 3 | -$0.28 | -$0.26 | -$0.27 |
| Q3 2024 | 1 | -$0.00 | -$0.00 | -$0.00 |
| Q4 2024 | 4 | $0.01 | $0.02 | $0.01 |
| Q1 2025 | 3 | -$0.75 | -$0.68 | -$0.71 |
| Q2 2025 | 2 | -$0.55 | -$0.50 | -$0.52 |
| Q3 2025 | 2 | -$0.50 | -$0.45 | -$0.47 |
| Q4 2025 | 2 | -$0.49 | -$0.45 | -$0.47 |
| Q1 2026 | 1 | -$0.68 | -$0.62 | -$0.65 |
| Q2 2026 | 1 | -$0.38 | -$0.35 | -$0.36 |
| Q3 2026 | 1 | -$0.36 | -$0.33 | -$0.34 |
| Q4 2026 | 1 | -$0.33 | -$0.30 | -$0.31 |
Castle Biosciences, Inc. Earnings Date And Information
Castle Biosciences, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.14. The company had revenue of 85.78 M for the quarter and had revenue of 219.79 M for the year. Castle Biosciences, Inc. has generated $-2 earnings per share over the last year ($-2.14 diluted earnings per share) and currently has a price-to-earnings ratio of 132.35. Castle Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Castle Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$0.06 | $0.08 | 0.14 | $79.85 M | $85.78 M |
| 08/05/2024 | Q2 2024 | -$0.27 | $0.32 | 0.59 | $69.37 M | $87.00 M |
| 05/02/2024 | Q1 2024 | -$0.37 | -$0.09 | 0.28 | $72.97 M | |
| 02/28/2024 | Q4 2023 | -$0.84 | -$0.10 | 0.74 | $66.12 M | |
| 11/02/2023 | Q3 2023 | -$0.92 | -$0.26 | 0.66 | $48.57 M | $61.49 M |
| 08/02/2023 | Q2 2023 | -$1.01 | -$0.70 | 0.31 | $44.19 M | $50.14 M |
| 05/03/2023 | Q1 2023 | -$0.80 | -$1.10 | -0.3 | $42.04 M | |
| 02/28/2023 | Q4 2022 | -$0.91 | -$0.78 | 0.13 | $38.34 M | |
| 11/02/2022 | Q3 2022 | -$0.70 | -$0.72 | -0.02 | $34.76 M | $37.01 M |
| 08/08/2022 | Q2 2022 | -$0.58 | -$0.06 | 0.52 | $28.37 M | $34.84 M |
| 05/09/2022 | Q1 2022 | -$0.67 | -$0.97 | -0.3 | $26.85 M | |
| 02/28/2022 | Q4 2021 | -$0.43 | -$0.25 | 0.18 | $25.04 M | |
| 11/08/2021 | Q3 2021 | -$0.35 | -$0.47 | -0.12 | $22.97 M | $23.48 M |
| 08/09/2021 | Q2 2021 | -$0.29 | -$0.35 | -0.06 | $19.11 M | $22.76 M |
| 05/10/2021 | Q1 2021 | -$0.22 | -$0.17 | 0.05 | $22.81 M | |
| 03/11/2021 | Q4 2020 | -$0.24 | $17.30 M | |||
| 11/09/2020 | Q3 2020 | -$0.06 | -$0.23 | -0.17 | $15.00 M | $15.22 M |
| 08/10/2020 | Q2 2020 | -$0.42 | -$0.08 | 0.34 | $8.80 M | $12.72 M |
| 05/11/2020 | Q1 2020 | -$0.15 | $0.03 | 0.18 | $17.42 M | |
| 03/10/2020 | Q4 2019 | -$0.20 | $0.12 | 0.32 | $17.64 M |
Castle Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Castle Biosciences, Inc.'s earnings date?
Castle Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Castle Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Castle Biosciences, Inc. (:CSTL) reported $0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.14.
-
How can I listen to Castle Biosciences, Inc.'s earnings conference call?
The conference call for Castle Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Castle Biosciences, Inc.'s conference call transcript?
The conference call transcript for Castle Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Castle Biosciences, Inc. generate each year?
Castle Biosciences, Inc. (:CSTL) has a recorded annual revenue of $219.79 M.
-
How much profit does Castle Biosciences, Inc. generate each year?
Castle Biosciences, Inc. (:CSTL) has a recorded net income of $219.79 M. Castle Biosciences, Inc. has generated $-2.14 earnings per share over the last four quarters.
-
What is Castle Biosciences, Inc.'s price-to-earnings ratio?
Castle Biosciences, Inc. (:CSTL) has a price-to-earnings ratio of 132.35 and price/earnings-to-growth ratio is 0.51.
